Recent Stories by FDA
Oct 22, 2019 by FDA
Performance measures track the progress of the Center of Veterinary Medicine’s (CVM) Five-Year Plan for Supporting Antimicrobial Stewardship in Veterinary Settings.
Sep 27, 2019 by FDA
Expanded conditional approval has the potential to incentivize drug development and provide veterinarians with legally marketed new animal drugs.
Jul 15, 2019 by FDA
The FDA reminds harvesters that crops harvested from flooded fields are often unacceptable because of contamination.
Apr 03, 2019 by FDA
The FDA this week announced a funding opportunity and Request for Applications (RFA) for studies that can help target and define durs of use for certain medically important antimicrobial drugs approved for use in the feed of food-producing animals.
Mar 22, 2019 by FDA
This webinar is rescheduled from the original date of December 3, 2018.
Dec 06, 2018 by FDA
The FDA announced this week that it has requested that animal drug companies voluntarily revise the labels of drugs intended to treat internal parasites in livestock to add information about antiparasitic resistance.
Nov 28, 2018 by FDA
The FDA this week announced an open period for applications for grants to support the development of new animal drugs intended to treat uncommon diseases (minor uses) in major species, or to treat minor species (MUMS).
Nov 01, 2018 by FDA
This week, the FDA announced the Plant and Animal Biotechnology Innovation Action Plan to outline the key priorities the agency will pursue to support innovation in plant and animal biotechnology.
Sep 15, 2018 by FDA
On September 14, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) unveiled its five-year action plan for supporting antimicrobial stewardship in veterinary settings.
Aug 17, 2018 by FDA
On August 14, 2018, the Animal Drug and Animal Generic Drug User Fee Amendments of 2018 was signed into law to reauthorize the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA) programs.
Jul 18, 2018 by FDA
The FDA has approved NexGard (afoxolaner), a chewable tablet administered once monthly to dogs, for the prevention of Borrelia burgdorferi infections by killing Black-legged ticks, which carry the bacterium.